HHHideaki Hanaki

Hideaki Hanaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hideaki Hanaki has a total of 147 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unbound and Periprostatic Adipose Tissue Cefazolin Pharmacokinetics in Robotic-Assisted Radical Prostatectomy

    by Toshiaki Komatsu, Yuki Takahashi, Yoko Takayama, Yuto Akamada, Masaomi Ikeda, Hideyasu Tsumura, Daisuke Ishii, Kazumasa Matsumoto, Masatsugu Iwamura, Hirotsugu Okamoto, et al.

    Background/Objectives: This study aimed to describe the population pharmacokinetics of cefazolin (CFZ) using unbound serum and periprostatic adipose tissue concentrations and to optimize dosing regimens for patients undergoing robotic-assisted radical prostatectomy (RARP). Methods: We investigated the population pharmacokinetics of CFZ using 295 unbound serum and 67 periprostatic adipose tissue samples from 67 individuals. CFZ concentrations were determined in all samples. A nonlinear mixed-effects model was developed. The pharmacodynamic target was defined as maintaining unbound trough and periprostatic adipose tissue concentrations exceeding the minimum inhibitory concentration (MIC) against methicillin-susceptible Staphylococcus aureus (MSSA) for over 90% of the dosing interval (MIC90; 0.5 mg/L). Results: Systemic clearance of unbound CFZ was significantly associated with creatinine clearance (CLcr). In patients with normal renal function, simulations showed that a 1 g CFZ infusion over 15 min maintained unbound concentrations exceeding the MSSA MIC90 for >90% of the 3 h interval after the initial dose. Notably, in patients with mild renal impairment (CLcr ≤ 80 mL/min), a 5 h dosing interval also achieved a >90% probability of maintaining the target CFZ concentration. Conclusions: The simulations demonstrated that the probability of target attainment of >90% was maintained for up to 5 h in patients with mild renal impairment (CLcr ≤ 80 mL/min). These findings provide a pharmacokinetic rationale suggesting that the standard additional dose may not be necessary for this subgroup; however, future clinical studies are needed to validate safety and efficacy.

  • Open Access

    Inactivation Effects of Hypochlorous Acid, Chlorine Dioxide, and Ozone on Airborne SARS-CoV-2 and Influenza A Virus

    by Yasuo Imoto, Hidehito Matsui, Chihiro Ueda, Eri Nakajima, Hideaki Hanaki

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus are primarily transmitted through droplets or aerosols from patients. The inactivation effects of existing virus control techniques may vary depending on the environmental factors. Therefore, it is important to establish a suitable evaluation system for assessing virus control techniques against airborne viruses for further real-world implementation. This study aimed to assess the inactivating effects of chemical substances on SARS-CoV-2 and influenza A virus in the air using an established evaluation system. A mixture containing SARS-CoV-2 and influenza A virus in diluted saliva was nebulized into the designed 1 m3 chamber, and the virucidal effects of hypochlorous acid, chlorine dioxide, and ozone in the air samples at 23 ± 1 °C with 50 ± 5% relative humidity were determined using the plaque assay. Both viral infectivity titers decreased depending on chemical substance concentration and exposure time. The concentrations of hypochlorous acid, chlorine dioxide, and ozone in the air reached an approximately 2-log reduction of SARS-CoV-2 infectivity titer within 10 min at 0.02, 1.0, and 1.0 ppm, respectively. SARS-CoV-2 persisted in the air even under conditions where the influenza A virus was inactivated below the detection limits. These findings demonstrate that hypochlorous acid, chlorine dioxide, and ozone are effective in inactivating SARS-CoV-2 and influenza A virus in the air.


  • Open Access

    A Chemical Investigation Approach of the Paraconiothyrium sp. FKR-0637 Fungal Strain Enables the Isolation of the New Chlorinated Chromone, Nohocumone

    by Haruki Azami, Yoshihiro Watanabe, Takahito Ouchi, Mika Watabe, Hiroki Kojima, Yui Hirano, Saki Owada, Toshiyuki Tokiwa, Mayuka Higo, Kenichi Nonaka, et al.

    The discovery of novel natural products (NPs) from diverse microorganisms is essential for advancing drug discovery. In this study, a chemical approach was employed for NP exploration using the genus Paraconiothyrium sp. isolated from the root soil of Ficus microcarpa on Noho Island, Okinawa. Consequently, we isolated five compounds, including a new chromone, nohocumone (1), as well as four known compounds, known chromone (2), 10-norparvulenone (3), sclerotinin A (4), and calbistrin A (5), from the culture broth of Paraconiothyrium sp. FKR-0637. The planar structure of 1 were elucidated using 1D and 2D NMR analyses, HR-ESI-MS, and chemical derivatization. Chlorinated chromone 1 is a novel compound that was not previously isolated from Paraconiothyrium sp. These results contribute to expanding the structural diversity and collection of NPs that can be obtained from the culture broths of Paraconiothyrium sp.

  • Open Access

    SARS-CoV-2 Contamination on Healthy Individuals' Hands in Community Settings During the COVID-19 Pandemic

    by Hidehito Matsui, Miho Sugamata, Harumi Endo, Yumiko Suzuki, Yukiko Takarabe, Yukie Yamaguchi, Rei Hokari, Aki Ishiyama, Chihiro Ueda, Eri Nakajima, et al.

    Introduction Hand hygiene is an infection control measure for COVID-19 in our daily lives; however, the contamination levels of SARS-CoV-2 in the hands of healthy individuals remain unclear. Thus, we aimed to evaluate SARS-CoV-2 contamination levels by detecting viral RNA and viable viruses in samples obtained from the hands of 925 healthy individuals. Methods Swab samples were collected from the palms and fingers of healthy participants, including office workers, public officers, university students, university faculty and staff, and hospital staff between December 2022 and March 2023. The collected swab samples were analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for SARS-CoV-2 RNA detection. Viral RNA-positive samples were subjected to plaque assay to detect viable viruses. Results We collected 1,022 swab samples from the hands of healthy participants. According to the criteria for data collection, 97 samples were excluded, and 925 samples were analyzed using RT-qPCR. SARS-CoV-2 RNA was detected in three of the 925 samples. The viral RNA detection rate was 0.32% (3/925), and the viral RNA copy numbers ranged from 5.0×103 to 1.7×105 copies/mL. The RT-qPCR-positive samples did not contain viable viruses, as confirmed by the plaque assay results. Conclusions The detection rate of SARS-CoV-2 RNA from the hands of healthy individuals was extremely low, and no viable viruses were detected. These results suggest that the risk of contact transmission via hands in a community setting is extremely rare.


  • Open Access

    Fluctuation in SARS-CoV-2 Environmental Surface Contamination Levels in Homes Where Patients With COVID-19 Stayed for Recuperation

    by Hidehito Matsui, Chihiro Ueda, Eri Nakajima, Yukiko Takarabe, Yukie Yamaguchi, Yumiko Suzuki, Harumi Endo, Miho Sugamata, Yasuo Imoto, Hideaki Hanaki

    Introduction Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often occurs among family members. Elucidating where viable SARS-CoV-2 virions, and not just residual viral RNA, are present in the house is necessary to prevent the further spread of the coronavirus disease 2019 (COVID-19). We aimed to evaluate the environmental surface contamination levels of both SARS-CoV-2 RNA and viable viruses in the homes of housebound patients with COVID-19. Methods Environmental samples were collected from the households of three patients in April and July 2022 when the number of new COVID-19 cases in Japan was reported to be approximately 50,000 and 200,000 cases per day, respectively. For each case, samples were obtained from 19-26 household sites for seven consecutive days. SARS-CoV-2 RNA was examined in 455 samples through reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and RT-qPCR-positive samples were subjected to plaque assay to detect viable viruses. Results Among the 455 samples, 63 (13.8%) that were collected from patients’ pillows and comforters, doorknobs, chairs, and refrigerators tested positive by RT-qPCR. The maximum detection rate of SARS-CoV-2 RNA-positive samples in each case ranged from 20.0% to 57.7% on days 1 to 3. The detection rate gradually decreased to 0-5.3% as the days elapsed. Although all RT-qPCR-positive samples were examined, no viable viruses were detected in these samples. Conclusions Although environmental contamination of SARS-CoV-2 RNA was observed in the homes of housebound patients with COVID-19, no viable viruses were isolated. This suggests that the indirect transmission risk from fomites was low.


  • Open Access

    Levels of environmental contamination with SARS-CoV-2 in hospital rooms and salivary viral loads of patients with coronavirus disease 2019

    by Hidehito Matsui, Yusuke Suzuki, Sohei Nakayama, Takanori Asakura, Osamu Takeuchi, Kaori Kusatsugu, Chihiro Ueda, Eri Nakajima, Yumiko Suzuki, Harumi Endo, et al.


  • Open Access

    Assessment of environmental surface contamination with SARS-CoV-2 in concert halls and banquet rooms in Japan

    by Hidehito Matsui, Chihiro Ueda, Eri Nakajima, Yumiko Suzuki, Harumi Endo, Miho Sugamata, Yukiko Takarabe, Yukie Yamaguchi, Masako Honsho, Rei Hokari, et al.


  • Timing of re-dosing based on population pharmacokinetic-pharmacodynamics target attainment analysis of cefmetazole in subjects undergoing lower gastrointestinal surgery

    by Toshiaki Komatsu, Hinako Morita, Yoko Takayama, Yui Natsume, Yoshinori Tomoda, Hirohisa Miura, Takeo Sato, Takatoshi Nakamura, Masaya Toda, Hirotsugu Okamoto, et al.


  • Development of an immunochromatographic test for the detection of Mycoplasma pneumoniae GroES antigen

    by Hidehito Matsui, Makoto Sugimura, Megumi Inoue-Tsuda, Kazuya Iwabuchi, Hideaki Hanaki